Helix Medical acquires MedVenture

The acquisition reflects Helix Medical's interest in beefing up its capabilities, particularly in design, as recently reported by Plastics Today.

Established in 1998, MedVenture employs more than 260, and brings total employment at Helix Medical to close to 1,000.  MedVenture develops and manufactures minimally invasive surgical devices and catheter-based devices for medical device companies. Specific markets include endovascular, interventional cardiology, cardiovascular surgery, neurovascular, urology, oncology, and gynecology.

"MedVenture will deepen our resources in product design, development, and engineering and enable Helix to offer more comprehensive product lifecycle management and be a stronger strategic partner to our customers," said Dr. Jorg Schneewind, President and CEO of Helix Medical. "While our global reach, with now 10 facilities around the world, will allow MedVenture to expand their services into new regions and tap into Helix's core strengths in thermoplastic and silicone molding and extrusion plus specialty catheters and hypotubes. Overall, the combined companies deliver a perfect synergy of complimentary capabilities powered by highly innovative people, advanced technology, and leading-edge processes."

Helix Medical is a division of the Freudenberg Group.